☆ 4.6 Editorial Material

Screening of asymptomatic patients with elevated lipoprotein(a) levels by coronary computed tomography angiography

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Finding very high lipoprotein(a): the need for routine assessment

Nick S. Nurmohamed et al.

Summary: This study validates the increased risk of atherosclerotic cardiovascular disease (ASCVD) associated with very high levels of lipoprotein(a) [Lp(a)]. It also shows that routine assessment of Lp(a) can lead to significant risk reclassification.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overview

Ioannis Parthymos et al.

Summary: Advances in cardiovascular medicine have led to new treatments with proven efficacy in reducing deaths and improving quality of life. However, cardiovascular disease remains a significant burden. Lipoprotein (a) has emerged as a potential target for treatment due to its association with cardiovascular events. This review presents current evidence of the causal relationship between lipoprotein (a) and cardiovascular disease, explores the necessary magnitude of lipoprotein (a) lowering, and discusses current and investigational treatments and their potential costs.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Screening for coronary artery calcium in a high-risk population: the ROBINSCA trial

Sabine J. A. M. Denissen et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Screening for coronary artery calciumin a high-risk population: the ROBINSCA trial

Sabine J. A. M. Denissen et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)

Juhani Knuuti et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

The role of Lipoprotein(a) in cardiovascular disease: Current concepts and future perspectives

Michael A. Vavuranakis et al.

HELLENIC JOURNAL OF CARDIOLOGY (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies JACC State-of-the-Art Review

Khaled M. Abdelrahman et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes

Daniel F. Gudbjartsson et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Coronary Atherosclerotic Precursors of Acute Coronary Syndromes

Hyuk-Jae Chang et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

Predictive value of coronary computed tomography angiography in asymptomatic individuals with diabetes mellitus: Systematic review and meta-analysis

Ebba Beller et al.

JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)

Amit V. Khera et al.

CIRCULATION (2014)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

C. Baigent et al.

LANCET (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.